Retrospective analysis of patients with relapsed or refractory testicular nonseminous germ cell tumors treated with autologous stem cell transplantation

CONCLUSION: Although the number of the patients in this study is limited, ASCT seems to be a safe and effective treatment modality in relapsed refractory non-seminomatousTGCT with an acceptable OS, PFS and mortality rates.

Source: Indian Journal of Cancer - February 21, 2018 Category: Cancer & Oncology Authors: F Yilmaz N Soyer R Uslu AP Erdogan B Karaca G Saydam F Sahin F Vural Source Type: research